Pengcheng Shi

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatmentsAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2026
Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP -inf mutations: Insights from a multicentre Chinese cohort study.

|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.

Guopan Yu, Yu Zhang, Sijian Yu

|Mar 11, 2024
Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy.

Xi Jia, Naying Liao, Yunqian Yao

|Mar 08, 2024
Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.

Xi Jia, Naying Liao, Sijian Yu

|Oct 20, 2020
Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response.

Pengcheng Shi, Jie Zha, Juan Feng

|Oct 15, 2020
Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.

Jie Zha, Qian Lai, Manman Deng

Pageof 1

Frequent Collaborators

2 joint publications

Jie Zha

2 joint publications

Manman Deng

2 joint publications

Haijun Zhao

2 joint publications

Bing Xu